Objective: Moderate alcohol consumption is associated with a decreased risk of type II diabetes. This study investigates the effect of moderate alcohol consumption on adipokines and insulin sensitivity. Subjects: Twenty healthy, lean (body mass index (BMI) 18.5-25 kg/m 2 ; n ¼ 11) or overweight (BMI427 kg/m 2 ; n ¼ 9) men (18-25 years). Methods: Three cans of beer (40 g alcohol) or alcohol-free beer daily during 3 weeks. Results: Adiponectin and ghrelin concentrations increased (Po0.01) by 11 and 8%, while acylation-stimulating protein (ASP) concentrations decreased by 12% (P ¼ 0.04) after moderate alcohol consumption. Concentrations of leptin and resistin remained unchanged. Insulin sensitivity by an oral glucose tolerance test (OGTT) was not affected by moderate alcohol consumption, but 2 h glucose concentrations were lower (P ¼ 0.01) after beer (4.570.1 mmol/l) than alcohol-free beer (4.970.1 mmol/l). Both free fatty acids and glucagon concentrations showed a stronger increase (Po0.01) after 90 min during OGTT after beer than alcohol-free beer. Changes of adiponectin were positively correlated (r ¼ 0.69, Po0.001), and changes of leptin (r ¼ À0.53, P ¼ 0.016) and ASP (r ¼ À0.43, P ¼ 0.067) were negatively correlated with changes of insulin sensitivity index. All these results did not differ between lean and overweight men. Conclusions: Moderate alcohol consumption increased adiponectin and ghrelin, while it decreased ASP concentrations both in lean and overweight men. These changes are in line with the hypothesized improvement of insulin sensitivity, but did not affect insulin sensitivity within 3 weeks of moderate alcohol consumption.
Introduction
Moderate alcohol consumption is associated with a decreased risk of type II diabetes (Koppes et al., 2005) , which could be explained by improved insulin sensitivity after moderate alcohol consumption (Davies et al., 2002; Sierksma et al., 2004) . Positive associations between alcohol consumption and insulin sensitivity are consistently reported in crosssectional studies (Kiechl et al., 1996; Bell et al., 2000) , but randomized controlled studies report contradictory results (Cordain et al., 1997; Cordain et al., 2000; Davies et al., 2002; Zilkens et al., 2003; Beulens et al., 2006) . Sierksma et al. (2004) suggested that an increase of adiponectin could precede changes of insulin sensitivity with moderate alcohol consumption. Adiponectin is thought to improve insulin sensitivity by increased glucose uptake and fatty acid oxidation in muscle tissue (Yamauchi et al., 2001) . Adipose tissue secretes several other proteins that may also be related to insulin sensitivity (Havel, 2004; Meier and Gressner, 2004) . The adipokines leptin and resistin are inversely associated with insulin sensitivity (Havel, 2004; Meier and Gressner, 2004) . Acylation-stimulating protein (ASP) stimulates storage of free fatty acids (FFA) as triglycerides in adipose tissue, but also increases glucose uptake (Havel, 2004) . ASP-deficient mice indeed have decreased clearance of FFA, but improved insulin sensitivity (Murray et al., 1999) . Similarly, plasma ASP concentrations are inversely correlated to insulin sensitivity in humans (Koistinen et al., 2001) . Ghrelin, a peptide produced in the fundus of the stomach, is known as a regulator of food intake (Meier and Gressner, 2004) , and ghrelin concentrations are positively associated with insulin sensitivity (Poykko et al., 2003; Purnell et al., 2003) .
Decreased FFA concentrations could mediate (Avogaro et al., 2002; Avogaro et al., 2004; Furuya et al., 2005) improved insulin sensitivity with moderate alcohol consumption, but the mechanism still is not entirely clear. Possibly, early changes of adipokines could play a role. Therefore, we studied the effect of moderate alcohol consumption on adipokines and insulin sensitivity. We hypothesized that changes of adiponectin and ghrelin are positively, and changes of leptin, resistin and ASP are negatively associated with changes of insulin sensitivity.
Methods

Subjects
We recruited twenty healthy, nonsmoking, young men, aged 18-25 years from the pool of volunteers of TNO Quality of Life (Zeist, The Netherlands) and by advertisements in local newspapers. Subjects were considered healthy based on prestudy screening consisting of a medical history (including alcohol intake and family history of alcoholism), pre-study blood sampling and a physical examination. Eligible subjects consumed between 10 and 28 units alcohol per week, had a body mass index (BMI) between 18.5 and 25 kg/m 2 or BMI 427 kg/m 2 and no family history of alcoholism. The subjects were divided in a lean subgroup (BMI 18.5-25 kg/m 2 , n ¼ 11) and an overweight subgroup (BMI 427 kg/m 2 , n ¼ 9) to explore whether BMI modifies the effect of moderate alcohol consumption on study outcomes. A cutoff of 27 kg/m 2 was chosen to ensure sufficient contrast between both groups. Subjects gave written informed consent after the study was carefully explained. TNO Medical Ethics Committee approved the research protocol, and we conducted the study according to the Declaration of Helsinki (2000) and the International Conference on Harmonisation Guideline for Good Clinical Practice.
Study design
The study was performed according to a randomized, partially diet-controlled, crossover trial, consisting of two 3 week periods, each preceded by 1 week washout in which subjects were instructed not to consume alcohol. Subjects were randomized based on BMI group to the sequence beer (Amstel Bier, Amsterdam, The Netherlands; 5% vol alcohol) followed by alcohol-free beer (Amstel Malt Bier, Amsterdam, The Netherlands; o0.1% vol alcohol) or the other way around. They consumed three cans (990 ml) of beer or alcohol-free beer daily with the evening meal, equaling 40 g alcohol per day during beer treatment. Subjects were instructed not to change their diet and physical activity throughout the study. They filled in daily questionnaires about their diet and physical activity, and lifestyle during the study and significant deviations from our instructions were recorded. Their diet was fully controlled during the last 10 days of each treatment period when all food was supplied by TNO. The composition of the diet was based on the Dutch Food Consumption Survey of 1998 (Voedingscentrum, 2003) and consisted of 37 energy% fat, 15 energy% protein and 48 energy% carbohydrates, excluding energy from alcohol, and was adjusted to body weight and physical activity level of the participants. Differences in energy or carbohydrate content between beer and alcohol-free beer were compensated for by the diet. During the entire study period (including washout periods), subjects were not allowed to drink any alcoholic beverages, besides those supplied. Body weight was measured in every visit and compliance was checked by daily questionnaires, return of empty cans and measuring ethyl glucuronide, a direct metabolite of alcohol consumption in the urine (Sarkola et al., 2003) and high-density lipoprotein (HDL) cholesterol.
Oral glucose tolerance test, blood and urine sampling and analysis Subjects visited TNO at the end of each treatment period after an overnight fast for an oral glucose tolerance test (OGTT) (75 g glucose dissolved in 300 ml water) and blood sampling before (fasting) and 30, 60, 90, 120 and 150 min after the glucose-load to assess glucose, insulin, FFA and glucagon concentrations. Fasting samples were used for determination of adipokines. Blood was collected from the antecubital vein in tubes containing clot activator (for serum) and in ice-chilled tubes containing citrate thiophylline, adenosine and dipyridamole for plasma (Vacutainer Systems, Becton Dickinson, Plymouth, UK), centrifuged for 15 min at 2 000 g at 4 1C and stored at À80 1C. Urine was collected during 24 h on the last 2 days of the study and samples were stored at À80 1C. Serum glucose was determined by hexokinase with a commercially available kit (Roche reagens, Mannheim, Germany). Serum insulin was determined by immunoenzymometric assay (Tosho, Tokyo, Japan). FFA levels were determined enzymatically (Randox Laboratories, Antrim, UK) and glucagon by EIA (Linco Research, Inc., St Charles, MO, USA). Adiponectin, leptin, ghrelin (Linco Research, Inc., St Charles, MO, USA) and ASP (Amersham Biosciences AB, Uppsala, Sweden) concentrations were determined by radioimmunoassay and resistin levels by enzyme-linked immunosorbent assay (BioVendor, Brno, Czech Republic). HDL was measured by homogenous enzymatic colorimetric (Roche reagens). Ethyl glucuronide in 24 h urine was determined according to Sarkola et al. (2003) .
Power calculation
Sample size of this study was based on a power calculation according to Schouten (Schouten, 1995) for the insulin sensitivity index (ISI) according to Cederholm (Cederholm and Wibell, 1990) . The correlation coefficient of this index with the clamp technique was estimated at 0.62 (Matsuda and DeFronzo, 1999) . Based on previous studies (Cederholm and Wibell, 1990; Davies et al., 2002; Sierksma et al., 2004) , a sample size of 20 is sufficient to detect a 12% difference in ISI with a power of 80% and accepting a two-sided a of 0.05. The subgroups of 10 subjects would enable us to detect a 15% difference in ISI.
Statistical analysis
Data were analyzed using the SAS statistical software package (SAS/STAT Version 8, SAS Institute, Cary, NC, USA). ISI's were calculated based on the OGTT according to Cederholm and Gutt (Cederholm and Wibell, 1990; Gutt et al., 2000) . Treatment effects were assessed by analysis of variance (ANOVA) using a mixed model with BMI, treatment order, period, treatment, and the interaction between BMI and treatment included in the model. The interaction between period and treatment was also included to test for possible carryover effects, with no significant effects detected. Differences between lean and overweight men were obtained from the main BMI effect from this ANOVA model. Body weight was included in the model as a random factor to adjust for changes of body weight. Treatment effects during the OGTT (curves over time) were analyzed by ANOVA for repeated measurements (time Â treatment interaction) using the same models as for ANOVA. Correlation coefficients were computed according to Spearman to assess associations between changes (alcohol-free beer minus beer) in outcome measures. Two-sided P-values below 0.05 were considered statistically significant. Table 1 shows the characteristics of our study population obtained from pre-study screening. BMI of lean and obese subgroups differed profoundly, reflected in differences of total HDL, LDL (low-density lipoprotein) cholesterol and triglycerides and liver enzymes. An indication for good compliance was the 18% increase (Po0.001) of fasting serum HDL cholesterol after beer as compared to alcohol-free beer consumption. Moreover, urinary ethyl glucuronide concentration after consumption of beer was 6.670.6 mg/l, while no ethyl glucuronide was detected (070 mg/l) after consumption of alcohol-free beer. No significant deviations to the treatment protocol and lifestyle instructions were reported. On average, subjects lost weight during the study, but this decrease was slightly higher (P ¼ 0.02) during the alcohol-free beer (À1.370.2) than the beer-drinking period (À0.670.2). Results were adjusted for this difference in body weight, but did not essentially change. The unadjusted results are therefore presented here.
Results
Adipokines
Plasma adiponectin concentration increased by 11% and plasma ghrelin concentrations increased by 8%, while plasma ASP decreased by 12% after consumption of beer compared to alcohol-free beer (Table 2) . Serum leptin and resistin concentrations remained unchanged (Table 2 ). Figure 1 shows the results of serum glucose, insulin, FFA and glucagon concentrations during the OGTT after beer and alcohol-free beer consuming periods. A total of 2 h glucose concentration was lower (P ¼ 0.01) after beer (4.570.1 mmol/l) than alcohol-free beer (4.970.1 mmol/l) consumption (Figure 1a) . Serum insulin concentrations were not different after beer than alcohol-free beer consumption (Figure 1b) . FFA concentrations showed a larger increase during the last hour of the OGTT after beer than alcohol-free beer consumption (Figure 1c) . Similar results were observed for glucagon concentrations (Figure 1d ). ISI Cederholm was not affected by beer compared with alcohol-free beer consumption, but ISI Gutt tended to increase after beer consumption (Table 2) .
OGTT
BMI effects
Plasma adiponectin and resistin were not different between overweight and lean subjects, but plasma leptin and ASP were higher in overweight subjects, while plasma ghrelin tended to be lower in overweight than lean subjects (Table 3) . Fasting glucose levels were higher (P ¼ 0.03) among overweight than lean subjects, but changes over time were not different ( Figure 2a ). Serum insulin was higher (Po0.03) among overweight than lean subjects at all but one time points (Figure 2b ). Changes of plasma FFA during OGTT were different between lean and overweight men (Figure 2c ). Plasma glucagon was higher (Po0.07) in overweight than lean subjects throughout the curve (Figure 2d ). 
Discussion
This study showed that moderate alcohol consumption increased adiponectin and ghrelin and decreased ASP concentrations. These changes are in line with the hypothesized improvement of insulin sensitivity, but did not Moderate alcohol consumption, adipokines and insulin sensitivity JWJ Beulens et al affect insulin sensitivity within 3 weeks. Changes in adiponectin were positively associated with changes in insulin sensitivity, while changes of leptin and ASP were modestly, negatively correlated with changes in insulin sensitivity.
This study was performed according to a randomized, controlled crossover design with a controlled diet during the last 10 days of each treatment period. Changes of body weight were slightly different between interventions, but adjustment for these changes did not essentially change the results. In addition, no significant deviations from treatment and lifestyle instructions were reported in daily questionnaires. It therefore seems unlikely that our results are distorted by changes in body weight, diet or lifestyle. Differences in body weight loss between beer and alcoholfree beer are in line with observational studies showing positive associations between body weight and alcohol consumption particularly for male populations and beer consumption (Wannamethee et al., 2005) . Furthermore, HDL cholesterol increased by 18% after beer consumption and urinary ethyl glucuronide was not detected during the alcohol-free period, indicating good compliance to study treatments.
Changes of plasma adiponectin, ghrelin and ASP concentrations observed in this study after moderate alcohol consumption are in line with the hypothesized increase of insulin sensitivity. In addition, changes of adiponectin, ASP and leptin were associated with changes of insulin sensitivity. This study is the first to show that moderate alcohol consumption decreases ASP concentrations. Only two previous trials investigated acute (van Oostrom et al., 2004) or chronic (Matthan et al., 2001 ) effects of macronutrients on ASP concentrations. A recent trial showed an acute decrease of ASP after exercise training that was negatively associated with insulin sensitivity (Schrauwen et al., 2005) . Our results after 3 weeks of moderate alcohol consumption are consistent with these finding. They are also in line with the increase of insulin sensitivity in ASP-deficient mice (Murray et al., 1999) and the inverse correlation of ASP with insulin sensitivity observed by Koistinen et al. (2001) in diabetic and nondiabetic men. Similarly, our results on leptin and adiponectin are consistent with previous observations. A study of Roth et al. (2003) showed a negative association of leptin with insulin sensitivity. Sierksma et al. (2004) showed an alcohol-induced increase of adiponectin, positively associated with insulin sensitivity. We could, however, not confirm differences in adiponectin concentrations between lean and overweight men. This may relate to lower power for these between-group differences as opposed to withinperson changes. Alternatively, adiponectin may be more related to insulin-mediated glucose disposal than obesity (Abbasi et al., 2004) . Since we observed similar glucose concentrations of lean and overweight subjects, this may explain similar adiponectin concentrations.
Ghrelin and resistin were not associated with insulin sensitivity, in line with contradictory reports on these associations. Studies showed that ghrelin may affect insulin sensitivity by stimulating tyrosine phosphorylation of IRS-1 (Murata et al., 2002) and insulin secretion (Date et al., 2002) , but increased gluconeogenesis (Murata et al., 2002) and decreased insulin release after ghrelin infusion have also been reported (Broglio et al., 2001) . Ghrelin could therefore be indirectly related to insulin sensitivity via effects on energy metabolism and body weight (Meier and Gressner, 2004) . Initial animal studies suggested that resistin influences glucose homeostasis (Asensio et al., 2004) , but this was not always confirmed in human studies (Janke et al., 2002; Lee et al., 2003) . This may be due to differences in physiology of resistin between mice and humans. On the other hand, resistin may be associated with inflammation rather than insulin sensitivity in humans (Gomez-Ambrosi and Fruhbeck, 2001; Lee et al., 2003) . We indeed observed in this study that changes of resistin correlated with changes of high-sensitive C-reactive protein (CRP) (r ¼ 0.47; P ¼ 0.034; unpublished data).
Despite changes of adipokines, moderate alcohol consumption did not affect insulin sensitivity in this study. Our relatively small sample size could preclude detection of small effects on insulin sensitivity. However, we observed a difference in ISI of only 2.5% with a confidence interval ranging from À5 to þ 9%. The width of this confidence interval excludes the 12% change that was a priori considered reasonable, showing that this study had sufficient power to detect our estimated change.
Our results are contradictory to a randomized controlled trial of Davies et al. (2002) . This disparity may be due to the different methods used for evaluating insulin sensitivity that reflect different aspects of insulin sensitivity. The OGTT and ISI used in our study are suggested to represent peripheral insulin sensitivity (Cederholm and Wibell, 1990 ) and were chosen because moderate alcohol consumption has been proposed to specifically affect peripheral insulin sensitivity (McCarty, 2001) . However, one of our previous studies applying the hyperinsulinemic, euglycemic clamp technique, representing whole-body insulin sensitivity, showed similar results as reported here (Beulens et al., 2006) . Furthermore, ISI calculated according to Matsuda and DeFronzo (1999) reflecting whole-body insulin sensitivity showed similar results. It is therefore unlikely that our results are explained by the method used. Other experimental conditions such as the 3 week treatment period of our study may also play a role. Possibly this period may have been too short compared to the 8 week intervention of Davies et al. (2002) .
Although ISI, our primary end point for insulin sensitivity, was not different between beer and alcohol-free beer, we indeed observed some subtle changes during the OGTT such as a decreased 2 h glucose concentration that could precede changes of insulin sensitivity. FFA and glucagon concentrations were also increased during the last hour of the curve after beer consumption. Some studies report that increased 2 h FFA or glucagon concentrations are related to impaired glucose tolerance (Laws et al., 1997; Ahren and Larsson, 2001) . However, such impaired glucose tolerance particularly leads to a decreased suppression of FFA and glucagon in the first 30 min of the curve in response to insulin secretion (Laws et al., 1997; Ahren and Larsson, 2001 ). We only observed increased FFA and glucagon concentrations during the last hour. This suggests that FFAs are released earlier as energy fuel and glucagon to counteract the lower 2 h glucose concentration. Longer interventions may be needed to observe changes of insulin sensitivity with moderate alcohol consumption.
In conclusion, moderate alcohol consumption increased adiponectin and ghrelin, while it decreased ASP concentrations. These changes are in line with the hypothesized improvement of insulin sensitivity, but did not lead to an increase of insulin sensitivity after moderate alcohol consumption. Adiponectin may particularly predict changes of insulin sensitivity, but longer interventions may be needed to detect changes of insulin sensitivity with moderate alcohol consumption.
